Blog

/Blog
Blog2018-03-04T18:00:55+00:00
204, 2018

Prefilled Syringe Manufacturing for Biopharmaceuticals

By |April 2nd, 2018|Categories: Manufacturing|Tags: , , |0 Comments

Regulations in this sector are rapidly tightening, but advances in materials and manufacturing techniques can help manufacturers meet rising expectations. As biopharmaceutical formulations capture ever-greater market share, demand for self-administered delivery systems has fueled rapid advances in the manufacturing of prefilled syringes. With increasing volume have come innovations in packaging [...]

903, 2018

3 Challenging Complexities of Preclinical Toxicology Studies

By |March 9th, 2018|Categories: Research & Development|Tags: , |0 Comments

Before a drug can proceed to the clinical trial stage, its developer must first pinpoint its likelihood of harming people by performing in vitro and in vivo toxicological studies. These studies involve a number of technical complexities, of which the following three are particularly challenging: 1. In vitro toxicology [...]

703, 2018

7 Critical Reasons to Invest in Pharmaceutical Analytical Services

By |March 7th, 2018|Categories: Analytical|Tags: , , , |0 Comments

Manufacturing competencies aren't the only reasons to partner with a contract manufacturing organization (CMO). Throughout every stage of your pharma development process, analytics can help increase efficiency, raise margins, and keep you ahead of your competition in all seven of the following ways: 1. Validation programs characterize useful compounds, [...]

603, 2018

5 Major Benefits of Vero Vaccine Development Pipelines

By |March 6th, 2018|Categories: Manufacturing|Tags: , , , , , |0 Comments

Rapid virus evolution challenges the medical industry with new strains every year. The Vero cell platform meets these challenges with a streamlined system for the rapid development of novel vaccines. The platform has proven effective at developing vaccines for SARS, avian influenza and other evolving threats, for the following [...]

1302, 2018

Blow-Fill-Seal

By |February 13th, 2018|Categories: Manufacturing|Tags: , , , |0 Comments

This innovative process mitigates risks associated with the sterile biologics manufacturing. However, tight control of parameters is critical. The risk of contamination is always present throughout any pharmaceutical manufacturing pipeline. That risk is particularly acute in biologics fill and finish. For that reason, a growing number of biologic manufacturers are [...]

602, 2018

Injectable Biologic Formulation Development

By |February 6th, 2018|Categories: Manufacturing, Research & Development|Tags: , , , , |0 Comments

The field has advanced considerably in recent years, but a number of key challenges remain. by Raymond E Peck, CEO of VxP Biologics Because injectable biologics are introduced directly into the body’s tissues, these formulations must be extraordinarily free from contamination of every kind. This requirement sets a high bar [...]